Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Food for healing: study tests if grocery delivery helps cancer patients finish treatment

NCT ID NCT01603316

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether providing food assistance—like vouchers, grocery delivery, or a hospital food pantry—helps cancer patients finish their treatment. About 600 patients with breast cancer who struggle to afford food will be randomly assigned to one of three programs. Researchers will track treatment completion and quality of life over six months.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
food assistance programs (food vouchers, home grocery delivery, hospital-based food pantry)
What this could lead to
If successful, this could show that providing reliable food support helps cancer patients finish their treatment and feel better overall.
What could go wrong
This is a mid-stage study, and results may vary by patient. The interventions address food access but not the cancer itself, so benefits may be limited.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 2

Tests whether the treatment actually works, and watches for side effects, in a larger group.

Participants

606 people

The number who actually took part.

Started

May 2012

Expected to finish

May 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Focus Groups Inclusion Criteria: * Breast cancer patient, Stage 1,2, or 3 * Currently undergoing treatment with chemotherapy and/or radiation * Food insecure: score in the range of "very low" or "low" food security status on the USDA Household Food Security Module (score of 3 or higher) * Language spoken: English or Spanish * Age 18 or over Intervention Inclusion Criteria: * Enrolled in ICCAN (for the original arms only: pantry only, pantry + delivery, pantry + voucher) * Within one month (+/- 1 month) of starting chemotherapy or within two weeks (+/- 2 weeks) of starting radiation therapy) (may be prior to or after starting treatment) * Score in the range of 'very low' or 'low' food security status on the USDA Household Food Security Module (score of 3 or higher) * Living independently (no patient in an assisted living facility) * Age 18 or over * Able to provide informed consent and respond to questionnaires in either English, Spanish or Mandarin (Mandarin for the original arms only: pantry only, pantry + delivery, pantry + voucher) * Breast or gynecologic cancer diagnosis, Stage 1, 2, or 3 (for the updated arms only: 1) Food Voucher Program (Voucher); 2) Home Grocery Delivery Program (Delivery); and 3) Medically-tailored, Hospital-based Food Pantry (Pantry) Clinician is eligible if he/she: * Has an MD or DO degree * Is the treating physician providing care to a patient enrolled to the study Secondary Aim 6 Needs Assessment eligibility criteria: * Current or past breast cancer diagnosis * Living independently (no patient in an assisted living facility) * Age 18 or over * Able to provide informed consent and respond to questionnaires in either English, or Spanish Exclusion Criteria: Focus Groups Exclusion Criteria: * Has a household member who has already participated (or agreed to participate) Intervention Exclusion Criteria: * Significant psychiatric disturbance verified by medical record sufficient to preclude completion of the assessment measures, interview or informed consent (i.e. acute psychiatric symptoms which require individual treatment) * Presence of cognitive impairment disorder (i.e. delirium or dementia) sufficient to preclude meaningful informed consent and/or data collection * Can not speak English, Spanish or Mandarin (Mandarin for the original arms only: pantry only, pantry + delivery, pantry + voucher) * Has physical limitations that would prevent participation (e.g. blindness) * Patient's household is currently receiving or applying for SNAP benefits (formerly known as Food Stamps) (for the original arms only: pantry only, pantry + delivery,pantry + voucher) Secondary Aim 6 Needs Assessment Exclusion criteria: * Significant psychiatric disturbance verified by medical record enough to preclude completion of the assessment measures, interview or informed consent (i.e. acute psychiatric symptoms which require individual treatment) * Presence of cognitive impairment disorder (i.e. delirium or dementia) enough to preclude meaningful informed consent and/or data collection * Cannot speak English or Spanish * Has physical limitations that would prevent participation (e.g. blindness) * Patient or family member has participated in other MSK IHCD trials related to social determinants of health

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Bellevue Hospital Center

    New York, New York, United States

  • Brooklyn Hospital Center

    Brooklyn, New York, 11201, United States

  • Jacobi Medical Center

    The Bronx, New York, 10465, United States

  • Lincoln Medical and Mental Health Center

    The Bronx, New York, United States

  • Memorial Sloan Kettering Cancer Center

    New York, New York, 10065, United States

  • Montefiore Health System (Montefiore Medical Center)

    The Bronx, New York, 10467, United States

  • New York Cancer & Blood Specialists (Data collection only)

    The Bronx, New York, 10469, United States

  • Queens Hospital Center

    Jamaica, New York, 11432, United States

  • Ralph Lauren Center for Cancer Care and Prevention

    New York, New York, United States

  • St. Barnabas Medical Center

    The Bronx, New York, 10457, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.